Sensus Healthcare (SRTS) News Today

Renaissance Technologies LLC lifted its position in Sensus Healthcare, Inc. (NASDAQ:SRTS - Free Report) by 34.4% in the second quarter, according to its most recent Form 13F filing with the SEC. The firm owned 391,534 shares of the company's stock after purchasing an additional 100,294 shares durin

Sensus Healthcare (NASDAQ:SRTS) Trading Up 5.1%

Sensus Healthcare, Inc. (NASDAQ:SRTS - Free Report) - Stock analysts at Roth Capital increased their FY2024 earnings per share (EPS) estimates for shares of Sensus Healthcare in a research note issued to investors on Friday, August 9th. Roth Capital analyst J. Wittes now forecasts that the compan

Sensus Healthcare (NASDAQ:SRTS) will be releasing earnings after the market closes on Thursday, August 8, Zacks reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=613354)

Roth Capital raised shares of Sensus Healthcare to a "strong-buy" rating in a research note on Friday.

Sensus Healthcare (NASDAQ:SRTS) Stock Crosses Below 50-Day Moving Average of $5.13

Sensus Healthcare, Inc. (NASDAQ:SRTS - Get Free Report) was the recipient of a large increase in short interest in the month of May. As of May 15th, there was short interest totalling 437,400 shares, an increase of 1,311.0% from the April 30th total of 31,000 shares. Approximately 3.3% of the shares of the stock are sold short. Based on an average trading volume of 513,200 shares, the short-interest ratio is currently 0.9 days.

Sensus Healthcare, Inc. (NASDAQ:SRTS - Get Free Report) Director John Heinrich sold 4,773 shares of Sensus Healthcare stock in a transaction on Friday, May 17th. The shares were sold at an average price of $5.95, for a total value of $28,399.35. Following the completion of the transaction, the director now owns 75,167 shares in the company, valued at approximately $447,243.65. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink.

Sensus Healthcare, Inc. (NASDAQ:SRTS - Free Report) - Stock analysts at HC Wainwright issued their Q2 2024 earnings estimates for Sensus Healthcare in a research note issued on Monday, May 13th. HC Wainwright analyst Y. Chen expects that the company will post earnings per share of $0.02 for the q

Sensus Healthcare, Inc. (NASDAQ:SRTS - Free Report) - Equities research analysts at HC Wainwright upped their Q4 2024 earnings per share (EPS) estimates for Sensus Healthcare in a research report issued to clients and investors on Monday, May 13th. HC Wainwright analyst Y. Chen now forecasts that

HC Wainwright upped their target price on Sensus Healthcare from $8.00 to $10.00 and gave the stock a "buy" rating in a research note on Monday.

Sensus Healthcare (NASDAQ:SRTS - Get Free Report) announced its quarterly earnings results on Thursday. The company reported $0.14 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.04) by $0.18. Sensus Healthcare had a return on equity of 1.04% and a net margin of 1.99%. The company had revenue of $10.66 million for the quarter, compared to the consensus estimate of $4.33 million. During the same quarter in the previous year, the business earned ($0.12) EPS.

Maxim Group raised their target price on shares of Sensus Healthcare from $7.00 to $10.00 and gave the company a "buy" rating in a report on Friday.

Sensus Healthcare (NASDAQ:SRTS) Share Price Passes Below 50-Day Moving Average of $3.72

Sensus Healthcare, Inc. (NASDAQ:SRTS - Get Free Report) was the recipient of a significant increase in short interest in the month of March. As of March 15th, there was short interest totalling 65,800 shares, an increase of 166.4% from the February 29th total of 24,700 shares. Currently, 0.5% of the shares of the company are sold short. Based on an average trading volume of 165,400 shares, the days-to-cover ratio is currently 0.4 days.

Sensus Healthcare, Inc. (NASDAQ:SRTS - Get Free Report) saw a large decline in short interest in February. As of February 29th, there was short interest totalling 24,700 shares, a decline of 50.0% from the February 14th total of 49,400 shares. Based on an average daily volume of 146,000 shares, the short-interest ratio is currently 0.2 days. Approximately 0.2% of the shares of the stock are sold short.